Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.4843
+0.0148 (3.15%)
At close: Jun 18, 2025, 4:00 PM
0.4999
+0.0156 (3.22%)
After-hours: Jun 18, 2025, 7:55 PM EDT

Entero Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Selling, General & Admin
6.9814.7210.7411.9918.387.29
Upgrade
Research & Development
0.370.95.030.6938.3219.14
Upgrade
Operating Expenses
7.3415.6215.7712.6856.726.43
Upgrade
Operating Income
-7.34-15.62-15.77-12.68-56.7-26.43
Upgrade
Interest Expense
-0.02--0.02-0.02-0.01-5.84
Upgrade
Interest & Investment Income
00-0.0100
Upgrade
Other Non Operating Income (Expenses)
-0.110-0-0.23-0-
Upgrade
EBT Excluding Unusual Items
-7.47-15.62-15.79-12.92-56.72-32.27
Upgrade
Asset Writedown
-----2.35-
Upgrade
Other Unusual Items
----1.710.53-0.4
Upgrade
Pretax Income
-7.47-15.62-15.79-14.63-58.54-32.67
Upgrade
Earnings From Continuing Operations
-22.33-15.62-15.79-14.63-58.54-32.67
Upgrade
Earnings From Discontinued Operations
-2.56-2.44----
Upgrade
Net Income
-24.89-18.06-15.79-14.63-58.54-32.67
Upgrade
Preferred Dividends & Other Adjustments
0.260.240.310.3425.989.06
Upgrade
Net Income to Common
-25.14-18.3-16.1-14.97-84.52-41.73
Upgrade
Shares Outstanding (Basic)
4300--
Upgrade
Shares Outstanding (Diluted)
4300--
Upgrade
Shares Change (YoY)
459.34%921.26%836.57%---
Upgrade
EPS (Basic)
-6.01-5.33-47.88-416.94--
Upgrade
EPS (Diluted)
-6.03-5.33-47.88-416.94--
Upgrade
Free Cash Flow
-6.29-9.22-12.38-22.34-32.36-11.23
Upgrade
Free Cash Flow Per Share
-1.50-2.68-36.80-622.19--
Upgrade
EBITDA
-7.34-15.61-15.74-12.65-56.16-25.87
Upgrade
D&A For EBITDA
0.010.010.030.030.540.57
Upgrade
EBIT
-7.34-15.62-15.77-12.68-56.7-26.43
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q